German Bionic
Category: Robotics / Embodied AI
A global leader in wearable robotics that develops AI-powered exoskeletons designed to augment human performance and protect worker health in physically demanding industries. German Bionic was founded in 2017. The company is led by Armin G. Schmidt. Based in Augsburg, Germany. Team size: 51-100. Total funding raised: $52.0M. Latest round: Acquired. Key investors include Archimedes Partners, Mubea, Samsung Catalyst Fund, MIG Capital, Storm Ventures, European Investment Bank (EIB), Benhamou Global Ventures, Bayern Kapital, IT Farm.
- Founded
- 2017
- Headquarters
- Augsburg, Germany
- Team size
- 51-100
- Total funding
- $52.0M
Value proposition
Reduces workplace injuries and musculoskeletal disorders by providing up to 84 lbs (38 kg) of adaptive lifting support plus active walking/carrying assistance, while using Physical AI / Augmented AI for real-time ergonomic data and safety alerts.
Products and solutions
Exia: Flagship AI-powered active back-support exoskeleton (up to 38 kg / 84 lbs); unveiled May 2025, CES 2026 Health Tech Award; current primary product., Apogee: Prior-generation smart robotic exoskeleton for industrial lifting and walking support., Apogee+: Medical/healthcare-oriented exoskeleton for patient handling and nursing., German Bionic IO: Cloud platform for ergonomic data, fleet insights, and Smart Safety Companion., German Bionic Connect: Mobile app for user settings, analytics, and coaching., Cray X: Earlier pioneering carbon-fiber connected exoskeleton.
Unique value
Pioneered the concept of 'Physical AI,' which integrates self-learning software with wearable hardware to adapt support levels dynamically based on the user's specific movements and fatigue levels.
Target customer
Logistics and warehousing providers, automotive manufacturers, healthcare facilities (nursing/patient care), and airport ground handling operations.
Industries served
Logistics & Supply Chain, Manufacturing & Automotive, Healthcare & Nursing, Aviation (Ground Handling), Construction
Technology advantage
Combines high-performance robotics with an IoT ecosystem; unlike passive suits, their active systems use motors and sensors to provide power, while the cloud connectivity allows for Over-the-Air (OTA) updates and enterprise-level ergonomic reporting.
How they differentiate
German Bionic differentiates through Physical AI / Augmented AI and active (powered) assistance. Unlike passive competitors that use springs or counterweights, Exia uses electric motors for up to 84 lbs (38 kg) of adaptive support, trained on billions of real-world motion data points. German Bionic IO provides ergonomic analytics and OTA updates.
Main competitors
Ottobock (SuitX), Ekso Bionics, Hilti, Sarcos Robotics
Key partnerships
Archimedes Partners (Owner / PE acquirer, Mar 2026), Mubea (Industrialization partner and Series A-II lead investor), Samsung Catalyst Fund (Strategic investor), European Investment Bank (Venture debt / R&D scaling), Charité – Universitätsmedizin Berlin (nursing research collaboration on Exia)
Notable customers
FedEx, Dachser, Pfizer, GXO, Canadian Tire, Currys, Charité – Universitätsmedizin Berlin, Nuremberg Airport, Maastricht Aachen Airport, DPD
Major milestones
CES 2023 Best of Innovation Award (Apogee), €15M EIB venture debt (Dec 2022), €15M Series A extension led by Mubea (Dec 2023), Exia unveiled May 2025 (WSJ Future of Everything); CES 2026 Health Tech Award, Filed for insolvency Nov 2025 amid failed financing; operations continued, Acquired by Archimedes Partners Mar 3, 2026; operating entity Advanced Bionic Systems GmbH
Growth metrics
CB Insights reported ~$5.09M revenue for FY2023; LinkedIn shows ~57 employees (51–100 band); company states deployments across 300+ companies worldwide (May 2026 Deep Tech Momentum post). Headcount 150+ and $10–25M revenue estimates appear overstated.
Market positioning
Premium enterprise-grade 'Smart Wearable' leader focusing on high-intensity logistics, aviation, and healthcare sectors.
Geographic focus
Europe (DACH region), North America (Boston-based US HQ), and Japan (Tokyo-based APAC HQ).
Patents and IP
Holds a robust portfolio of international patents covering human-machine interaction, exoskeleton control systems, and wearable sensor integration (specific patent filings include advancements in active power assistance and ergonomic data processing).
About Armin G. Schmidt
Benjamin Schulz is a Partner at Archimedes Partners (acquirer of German Bionic). He is the founder of Altitude and a former founding partner at Carbon Removal Partners; he studied Mathematics at Imperial College London and previously founded and built tech companies, with climate advocacy via CleanTechnica and The Solar Panel Art Series.
More Robotics / Embodied AI companies
Official website: https://www.germanbionic.com